ArticleInternational journal of telemedicine and applications2026
Patient-Centered Teledermatology: Bridging Pharmacies and Dermatologists.
Article in International journal of telemedicine and applications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Patient-Centered Teledermatology: Bridging Pharmacies and Dermatologists.International journal of telemedicine and applications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The chronic shortage of dermatologists in France results in average waiting times of 3 months, compromising equitable access to care and early diagnosis of severe conditions such as skin cancers. This pilot project evaluates the feasibility, effectiveness, and acceptability of a tele-expertise platform connecting community pharmacists and dermatologists. Methods: From March 2024 to March 2025, 40 pharmacies (18 urban and 22 rural) submitted 731 dermatological cases via a secure platform, following pharmacist training in clinical photography and best practices. Twelve volunteer dermatologists responded within a target of 24-48 h. Data focused on utilization, response times, pathologies, satisfaction (pharmacist surveys and pharmacist-reported patient feedback), and qualitative feedback from an expert board. Results: Seven hundred fourteen tele-expertises were completed, with a mean response time of 5.4 days, reflecting early implementation constraints and progressively improving over time (reduced to 1-2 days by study end; 83% < 48 h in February 2025). The main conditions include suspected melanoma (7), carcinomas (27), actinic keratosis, eczema, atopic dermatitis, rosacea, vitiligo, and shingles. Pharmacist satisfaction reached 72% (NPS 24%; 94% recommending a scale-up with adaptations). Pharmacists reported that 88% of patients were satisfied. Limitations comprised the lack of e-prescriptions and the nonintegration of primary care physicians. Conclusion: This pharmacy-centered model improves rapid access to dermatological expertise, reduces diagnostic delays, and satisfies users, but requires integration into coordinated care pathways (with primary care physicians), pharmacist remuneration, and legal/financial reforms for sustainability. A second pilot is testing these recommendations.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.